高通量定序(HTS) 市場規模、佔有率和成長分析：按技術、產品、應用、最終用戶、工作流程和地區分類－2026-2033 年產業預測

2024年全球高通量定序（HTS）市值為53億美元，預計將從2025年的57.8億美元成長到2033年的116.1億美元。預測期（2026-2033年）的複合年成長率預計為9.1%。

全球高通量定序(HTS) 市場正經歷顯著成長，這主要得益於快速 DNA 和 RNA 讀取技術的進步，這些技術使基因研究得以普及。推動這一成長的關鍵因素包括成本降低和通量提高，使得全基因測序從一項耗時高成本的長期計劃轉變為臨床和研究領域的標準操作。這種轉變對於精準癌症治療和感染疾病追蹤等應用至關重要，從而帶動了持續的市場需求。監管政策的明確和基因組分析保險覆蓋範圍的擴大進一步促進了對臨床應用和數據分析的投資。此外，人工智慧的整合透過流程自動化和提高變異解讀的準確性，提升了數據分析的效率，為軟體和服務引領市場創造了機會。

全球高通量定序(HTS) 市場促進因素

全球高通量定序(HTS) 市場的主要促進因素之一是對個人化醫療和基因組研究日益成長的需求。隨著我們對基因變異及其對健康影響的理解不斷加深，研究人員和醫療保健機構正在利用 HTS 技術開發個人化治療方法並改善患者預後。此外，遺傳疾病盛行率的上升以及對有效診斷工具需求的成長也推動了對先進定序技術的投資。 HTS 在腫瘤學、感染疾病和農業等各領域的應用，透過實現更全面、更有效率的基因分析，進一步加速了市場成長。

全球高通量定序(HTS) 市場的限制因素

全球高通量定序(HTS) 市場的主要限制因素之一是定序技術和必要基礎設施的高成本。除了對先進定序設備的初始投資外，小規模實驗室和研究機構在維護、試劑和專業人員方面的持續成本也可能非常高昂。這種經濟障礙可能會限制資金和資源本就有限的發展中地區採用 HTS 技術。此外，數據分析和解讀的複雜性需要專業知識，這可能會進一步限制 HTS 技術的普及，從而阻礙市場成長。

全球高通量定序（HTS）市場趨勢

全球高通量定序(HTS) 市場正呈現出顯著的趨勢，即整合人工智慧驅動的解讀生態系統，進而改變基因組分析的模式。相關人員方正日益利用人工智慧和機器學習技術來最佳化從序列到洞察的工作流程，並提高資料解讀的效率和一致性。供應商與生物資訊學專家之間的合作正在推動檢驗的流程和使用者友善介面的開發，從而最大限度地減少對專業人員的需求。對可互通軟體解決方案、標準化本體和雲端部署的關注，進一步增強了臨床和研究應用的擴充性，並透過訂閱平台、分析服務和綜合解讀解決方案開闢了新的收入來源。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢
• 價值鏈分析

全球高通量定序(HTS) 市場規模：依技術和複合年成長率分類 (2026-2033)

• 定序方法
  • 定序合成（SBS）
  • 離子半導體定序
  • 單分子即時（SMRT）
  • 奈米孔定序

全球高通量定序(HTS) 市場規模：依產品和複合年成長率 (2026-2033) 分類

• 試劑和耗材
• 裝置
• 軟體和服務

全球高通量定序(HTS) 市場規模：按應用和複合年成長率 (2026-2033) 分類

• 診斷用途
• 出於研究目的
• 農業用途
• 法醫學應用

全球高通量定序(HTS) 市場規模：依最終用戶和複合年成長率 (2026-2033) 分類

• 學術和研究機構
• 製藥和生物技術公司
• 醫院和診斷中心
• 受託研究機構（CRO）

全球高通量定序(HTS) 市場規模：依工作流程及複合年成長率分類 (2026-2033)

• 樣品製備
• 定序
• 數據分析

全球高通量定序(HTS) 市場規模及複合年成長率 (2026-2033)

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• Merck KGaA
• F. Hoffmann-LA Roche AG
• Abcam
• Cell Signaling Technology
• PerkinElmer
• Sino Biological
• BioGenex
• Illumina
• Pacific Biosciences
• 10x Genomics
• QIAGEN
• Oxford Nanopore Technologies
• Genomatix
• Ginkgo Bioworks
• BGI Group
• Asuragen
• Novogene

結論與建議

Global High-Throughput Sequencing (Hts) Market size was valued at USD 5.3 Billion in 2024 and is poised to grow from USD 5.78 Billion in 2025 to USD 11.61 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global high-throughput sequencing (HTS) market is experiencing significant growth, propelled by advancements in rapid DNA and RNA reading technologies that have democratized genetic research. Key factors driving this expansion include decreased costs and enhanced throughput, transforming whole-genome sequencing from lengthy, expensive projects into standard practices in clinical and research settings. This evolution is crucial for applications such as precision oncology and infectious disease tracking, leading to sustained market demand. Investment in clinical applications and data analytics further fuels growth, supported by regulatory clarity and payer coverage for genomic profiling. Additionally, the integration of AI enhances data analysis efficiency by automating processes and improving variant interpretation, creating opportunities for software and services to dominate the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global High-Throughput Sequencing (Hts) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global High-Throughput Sequencing (Hts) Market Segments Analysis

Global high-throughput sequencing (hts) market is segmented by technology, product, application, end-user, workflow and region. Based on technology, the market is segmented into Sequencing Methods. Based on product, the market is segmented into Reagents & Consumables, Instruments and Software & Services. Based on application, the market is segmented into Diagnostic Applications, Research Applications, Agricultural Applications and Forensic Applications. Based on end-user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers and Contract Research Organizations (CROs). Based on workflow, the market is segmented into Sample Preparation, Sequencing and Data Analysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global High-Throughput Sequencing (Hts) Market

One of the key market drivers for the Global High-Throughput Sequencing (HTS) Market is the increasing demand for personalized medicine and genomics research. As the understanding of genetic variations and their impact on health expands, researchers and healthcare providers are utilizing HTS technologies to develop tailored therapies and improve patient outcomes. Additionally, the growing prevalence of genetic disorders and the rising need for effective diagnostic tools are propelling investments in advanced sequencing technologies. The integration of HTS in various fields, such as oncology, infectious diseases, and agriculture, further accelerates market growth by enabling more comprehensive and efficient genetic analysis.

Restraints in the Global High-Throughput Sequencing (Hts) Market

One key market restraint for the global high-throughput sequencing (HTS) market is the high cost associated with sequencing technologies and the required infrastructure. The initial investment for advanced sequencing equipment, alongside ongoing expenses for maintenance, reagents, and skilled personnel, can be prohibitively expensive for smaller laboratories and research institutions. This financial barrier may limit the adoption of HTS technologies, particularly in developing regions where funding and resources are already constrained. Additionally, the complexity of data analysis and interpretation necessitates specialized expertise, which can further hinder market growth by restricting access to HTS capabilities.

Market Trends of the Global High-Throughput Sequencing (Hts) Market

The Global High-Throughput Sequencing (HTS) market is witnessing a significant trend towards the integration of AI-enabled interpretation ecosystems, which are transforming the landscape of genomic analysis. Stakeholders are increasingly leveraging artificial intelligence and machine learning technologies to optimize the sequence-to-insight workflow, boosting both efficiency and consistency in data interpretation. Collaborations between vendors and bioinformatics experts are leading to the development of validated pipelines and user-friendly interfaces, minimizing the need for specialized personnel. The focus on interoperable software solutions, standardized ontologies, and cloud-based deployments further enhances scalability for both clinical and research applications, paving the way for new revenue streams through subscription-based platforms, analytics services, and comprehensive interpretation offerings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis

Global High-Throughput Sequencing (HTS) Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Sequencing Methods
  • Sequencing Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT)
  • Nanopore Sequencing

Global High-Throughput Sequencing (HTS) Market Size by Product & CAGR (2026-2033)

• Market Overview
• Reagents & Consumables
• Instruments
• Software & Services

Global High-Throughput Sequencing (HTS) Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostic Applications
• Research Applications
• Agricultural Applications
• Forensic Applications

Global High-Throughput Sequencing (HTS) Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Contract Research Organizations (CROs)

Global High-Throughput Sequencing (HTS) Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sample Preparation
• Sequencing
• Data Analysis

Global High-Throughput Sequencing (HTS) Market Size & CAGR (2026-2033)

• North America (Technology, Product, Application, End-User, Workflow)
  • US
  • Canada
• Europe (Technology, Product, Application, End-User, Workflow)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End-User, Workflow)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End-User, Workflow)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End-User, Workflow)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann- LA Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asuragen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations